Impact of brief exercise on circulating monocyte gene and microRNA expression: Implications for atherosclerotic vascular disease

Brain, Behavior, and Immunity

Volumn 39, Issue , 2014, Pages 121-129

  Radom Aizik, Shlomit ^a   Zaldivar, Frank P ^a   Haddad, Fadia ^a   Cooper, Dan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epigenetics; Exercise immunology; Gene array; Genomics; Immune system; Leukocytes

Indexed keywords

AMPHIREGULIN; CD36 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EPIREGULIN; HEAT SHOCK COGNATE PROTEIN 70; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MICRORNA; MICRORNA 1202; MICRORNA 1305; MICRORNA 130A; MICRORNA 140 5P; MICRORNA 151 5P; MICRORNA 15A; MICRORNA 199A 3P; MICRORNA 221; MICRORNA 23B; MICRORNA 29B; MICRORNA 29C; MICRORNA 30E; MICRORNA 338 3P; MICRORNA 362 5P; MICRORNA 532 3P; MICRORNA 532 5P; MITOGEN ACTIVATED PROTEIN KINASE 7; NUCLEAR RECEPTOR NUR77; SUPPRESSOR OF CYTOKINE SIGNALING 3; THROMBOMODULIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BICYCLE ERGOMETER; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EXERCISE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MONOCYTE; MUTATION; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS; UPREGULATION; BLOOD; GENE EXPRESSION; METABOLISM; PHYSIOLOGY; YOUNG ADULT;

ADULT; ATHEROSCLEROSIS; EXERCISE; GENE EXPRESSION; HUMANS; MALE; MICRORNAS; MONOCYTES; YOUNG ADULT;

EID: 84902303004     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.01.003     Document Type: Article

References (69)

1. Ahmed H.M., Blaha M.J., Nasir K., Rivera J.J., Blumenthal R.S. Effects of physical activity on cardiovascular disease. Am. J. Cardiol. 2012, 109:288-295.
2. Berg K.E., Ljungcrantz I., Andersson L., Bryngelsson C., Hedblad B., Fredrikson G.N., Nilsson J., Bjorkbacka H. Elevated CD14++. Circ. Cardiovasc. Genet. 2012, 5:122-131.
3. Berger S., Dyugovskaya L., Polyakov A., Lavie L. Short-term fibronectin treatment induces endothelial-like and angiogenic properties in monocyte-derived immature dendritic cells: involvement of intracellular VEGF and MAPK regulation. Eur. J. Cell Biol. 2012, 91:640-653.
4. Bles N., Di P.L., Boeynaems J.M., Communi D. ATP confers tumorigenic properties to dendritic cells by inducing amphiregulin secretion. Blood 2010, 116:3219-3226.
5. Bruns A.F., Yuldasheva N., Latham A.M., Bao L., Pellet-Many C., Frankel P., Stephen S.L., Howell G.J., Wheatcroft S.B., Kearney M.T., Zachary I.C., Ponnambalam S. A heat-shock protein axis regulates VEGFR2 proteolysis, blood vessel development and repair. PLoS One 2012, 7:e48539.
6. Campos-Toimil M., Keravis T., Orallo F., Takeda K., Lugnier C. Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells. Br. J. Pharmacol. 2008, 154:82-92.
7. Chen K.C., Wang Y.S., Hu C.Y., Chang W.C., Liao Y.C., Dai C.Y., Juo S.H. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J. 2011, 25:1718-1728.
8. den Dekker W.K., Cheng C., Pasterkamp G., Duckers H.J. Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis 2010, 209:314-320.
9. Emmrich S., Henke K., Hegermann J., Ochs M., Reinhardt D., Klusmann J.H. MiRNAs can increase the efficiency of ex vivo platelet generation. Ann. Hematol. 2012, 91:1673-1684.
10. Estruch M., Bancells C., Beloki L., Sanchez-Quesada J.L., Ordonez-Llanos J., Benitez S. CD14 and TLR4 mediate cytokine release promoted by electronegative LDL in monocytes. Atherosclerosis 2013, 229:356-362.
11. Fantidis P. The role of intracellular 3'5'-cyclic adenosine monophosphate (cAMP) in atherosclerosis. Curr. Vasc. Pharmacol. 2010, 8:464-472.
12. Favre J., Terborg N., Horrevoets A.J. The diverse identity of angiogenic monocytes. Eur. J. Clin. Invest. 2013, 43:100-107.
13. Febbraio M., Silverstein R.L. CD36: implications in cardiovascular disease. Int. J. Biochem. Cell Biol. 2007, 39:2012-2030.
14. Ferri N. AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular disease. Vasc. Pharmacol. 2012, 56:9-13.
15. Findeisen H.M., Gizard F., Zhao Y., Qing H., Heywood E.B., Jones K.L., Cohn D., Bruemmer D. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition. Arterioscler. Thromb. Vasc. Biol. 2011, 31:851-860.
16. Gan A.M., Pirvulescu M.M., Stan D., Simion V., Calin M., Manduteanu I., Butoi E. Monocytes and smooth muscle cells cross-talk activates STAT3 and induces resistin and reactive oxygen species and production. J. Cell Biochem. 2013, 114:2273-2283.
17. Gear A.R., Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 2003, 10:335-350.
18. Gratchev A., Sobenin I., Orekhov A., Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases. Immunobiology 2012, 217:476-482.
19. Han H., Wang Y.H., Qu G.J., Sun T.T., Li F.Q., Jiang W., Luo S.S. Differentiated miRNA expression and validation of signaling pathways in apoE gene knockout mice by cross-verification microarray platform. Exp. Mol. Med. 2013, 45:e13.
20. Heimbeck I., Hofer T.P., Eder C., Wright A.K., Frankenberger M., Marei A., Boghdadi G., Scherberich J., Ziegler-Heitbrock L. Standardized single-platform assay for human monocyte subpopulations: lower CD14+CD16++ monocytes in females. Cytometry A 2010, 77:823-830.
21. Jaedicke K.M., Roythorne A., Padget K., Todryk S., Preshaw P.M., Taylor J.J. Leptin up-regulates TLR2 in human monocytes. J. Leukoc. Biol. 2013, 93:561-571.
22. Kin K., Miyagawa S., Fukushima S., Shirakawa Y., Torikai K., Shimamura K., Daimon T., Kawahara Y., Kuratani T., Sawa Y. Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J. Am. Heart Assoc. 2012, 1:e000745.
23. Kyotani Y., Ota H., Itaya-Hironaka A., Yamauchi A., Sakuramoto-Tsuchida S., Zhao J., Ozawa K., Nagayama K., Ito S., Takasawa S., Kimura H., Uno M., Yoshizumi M. Intermittent hypoxia induces the proliferation of rat vascular smooth muscle cell with the increases in epidermal growth factor family and erbB2 receptor. Exp. Cell Res. 2013, 319:3042-3050.
24. Kzhyshkowska J., Neyen C., Gordon S. Role of macrophage scavenger receptors in atherosclerosis. Immunobiology 2012, 217:492-502.
25. Liu D.Z., Tian Y., Ander B.P., Xu H., Stamova B.S., Zhan X., Turner R.J., Jickling G., Sharp F.R. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 2010, 30:92-101.
26. Lu C., Huang X., Zhang X., Roensch K., Cao Q., Nakayama K.I., Blazar B.R., Zeng Y., Zhou X. MiR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 2011, 117:4293-4303.
27. Lu X., Kakkar V. The role of heat shock protein (HSP) in atherosclerosis: pathophysiology and clinical opportunities. Curr. Med. Chem. 2010, 17:957-973.
28. Lu Z., Zhang X., Li Y., Jin J., Huang Y. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice. J. Endocrinol. 2013, 216:61-71.
29. Maffei R., Bulgarelli J., Fiorcari S., Bertoncelli L., Martinelli S., Guarnotta C., Castelli I., Deaglio S., Debbia G., De B.S., Bonacorsi G., Zucchini P., Narni F., Tripodo C., Luppi M., Cossarizza A., Marasca R. The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation. Haematologica 2013, 98:1115-1123.
30. Maharjan S., Kim K., Agrawal V., Choi H.J., Kim N.J., Kim Y.M., Suh Y.G., Kwon Y.G. Sac-1004, a novel vascular leakage blocker, enhances endothelial barrier through the cAMP/Rac/cortactin pathway. Biochem. Biophys. Res. Commun. 2013, 435:420-427.
31. Marketou M., Kintsurashvili E., Papanicolaou K.N., Lucero H.A., Gavras I., Gavras H. Cardioprotective effects of a selective B(2) receptor agonist of bradykinin post-acute myocardial infarct. Am. J. Hypertens. 2010, 23:562-568.
32. Markus H.S., Makela K.M., Bevan S., Raitoharju E., Oksala N., Bis J.C., O'Donnell C., Hainsworth A., Lehtimaki T. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke 2013, 44:1220-1225.
33. Maziere C., Maziere J.C. Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radic. Biol. Med. 2009, 46:127-137.
34. Mehta N.N., Reilly M.P. Monocyte mayhem: do subtypes modulate distinct atherosclerosis phenotypes?. Circ. Cardiovasc. Genet. 2012, 5:7-9.
35. Mograbi B., Rochet N., Imbert V., Bourget I., Bocciardi R., Emiliozzi C., Rossi B. Human monocytes express amphiregulin and heregulin growth factors upon activation. Eur. Cytokine Netw. 1997, 8:73-81.
36. Neth P., Nazari-Jahantigh M., Schober A., Weber C. MicroRNAs in flow-dependent vascular remodelling. Cardiovasc. Res. 2013, 99:294-303.
37. Nguyen B.K., Maltais S., Perrault L.P., Tanguay J.F., Tardif J.C., Stevens L.M., Borie M., Harel F., Mansour S., Noiseux N. Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. J. Cardiovasc. Transl. Res. 2010, 3:547-558.
38. Oliveira M., Gleeson M. The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men. Eur. J. Appl. Physiol. 2010, 109:251-257.
39. Ortega F.J., Mercader J.M., Catalan V., Moreno-Navarrete J.M., Pueyo N., Sabater M., Gomez-Ambrosi J., Anglada R., Fernandez-Formoso J.A., Ricart W., Fruhbeck G., Fernandez-Real J.M. Targeting the circulating microRNA signature of obesity. Clin. Chem. 2013, 59:781-792.
40. Ortiz-Munoz G., Martin-Ventura J.L., Hernandez-Vargas P., Mallavia B., Lopez-Parra V., Lopez-Franco O., Munoz-Garcia B., Fernandez-Vizarra P., Ortega L., Egido J., Gomez-Guerrero C. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:525-531.
41. Perry M.M., Baker J.E., Gibeon D.S., Adcock I.M., Chung K.F. Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma. Am. J. Respir. Cell Mol. Biol. 2013, 50:7-17.
42. Pradeu T., Cooper E.L. The danger theory: 20 years later. Front. Immunol. 2012, 3:287.
43. Radom-Aizik S., Zaldivar F., Oliver S., Galassetti P., Cooper D.M. Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes. J. Appl. Physiol. 2010, 109:252-261.
44. Radom-Aizik S., Zaldivar F.P., Haddad F., Cooper D.M. Impact of brief exercise on peripheral blood nk cell gene and microrna expression in young adults. J. Appl. Physiol. 2013, 114:628-636.
45. Ricciotti E., FitzGerald G.A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 2011, 31:986-1000.
46. Rink C., Khanna S. MicroRNA in ischemic stroke etiology and pathology. Physiol. Genomics 2011, 43:521-528.
47. Shantsila E., Tapp L.D., Wrigley B.J., Montoro-Garcia S., Ghattas A., Jaipersad A., Lip G.Y. The effects of exercise and diurnal variation on monocyte subsets and monocyte-platelet aggregates. Eur. J. Clin. Invest. 2012, 42:832-839.
48. Shantsila E., Tapp L.D., Wrigley B.J., Montoro-Garcia S., Lip G.Y. CXCR4 positive and angiogenic monocytes in myocardial infarction. Thromb. Haemost. 2013, 109:255-262.
49. Silver D.L., Wang N., Vogel S. Identification of small PDZK1-associated protein, DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levels. J. Biol. Chem. 2003, 278:28528-28532.
50. Simpson R.J., McFarlin B.K., McSporran C., Spielmann G., Hartaigh B., Guy K. Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans. Brain Behav. Immun. 2009, 23:232-239.
51. Steppich B., Dayyani F., Gruber R., Lorenz R., Mack M., Ziegler-Heitbrock H.W. Selective mobilization of CD14(+)CD16(+) monocytes by exercise. Am. J. Physiol. Cell Physiol. 2000, 279:C578-C586.
52. Vandercappellen J., Van D.J., Struyf S. The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer. Cytokine Growth Fact. Rev. 2011, 22:1-18.
53. Wassmann K., Wassmann S., Nickenig G. Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ. Res. 2005, 97:1046-1054.
54. Wei W., Jiao Y., Postlethwaite A., Stuart J.M., Wang Y., Sun D., Gu W. Dual-specificity phosphatases 2: surprising positive effect at the molecular level and a potential biomarker of diseases. Genes Immun. 2013, 14:1-6.
55. Wei Y., Schober A., Weber C. Pathogenic arterial remodeling: the good and bad of microRNAs. Am. J. Physiol. Heart Circ. Physiol. 2013, 304:H1050-H1059.
56. Wight T.N., Merrilees M.J. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 2004, 94:1158-1167.
57. Wong K.L., Yeap W.H., Tai J.J., Ong S.M., Dang T.M., Wong S.C. The three human monocyte subsets: implications for health and disease. Immunol. Res. 2012, 53:41-57.
58. Wong K.L., Tai J.J.-Y., Wong W.C., Han H., Sem X., Yeap W.H., Kourilsky P., Wong S.C. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011, 118:e16-e31.
59. Woollard K.J. Immunological aspects of atherosclerosis. Clin. Sci. (Lond.) 2013, 125:221-235.
60. Yadav A.K., Kumar V., Jha V. Heat shock proteins 60 and 70 specific proinflammatory and cytotoxic response of CD4(+) CD28(null) cells in chronic kidney disease. Mediat. Inflamm. 2013, 2013:384807.
61. Yamamoto M., Singh A., Sava F., Pui M., Tebbutt S.J., Carlsten C. MicroRNA expression in response to controlled exposure to diesel exhaust: attenuation by the antioxidant N-acetylcysteine in a randomized crossover study. Environ. Health Perspect. 2013, 121:670-675.
62. Yehuda H., Szuchman-Sapir A., Khatib S., Musa R., Tamir S. Human atherosclerotic plaque lipid extract promotes expression of proinflammatory factors in human monocytes and macrophage-like cells. Atherosclerosis 2011, 218:339-343.
63. Yougbare I., Boire G., Roy M., Lugnier C., Rouseau E. NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-kappaB signalling pathways while reducing proinflammatory cytokine production. Can. J. Physiol. Pharmacol. 2013, 91:353-361.
64. Zawada A.M., Rogacev K.S., Schirmer S.H., Sester M., Bohm M., Fliser D., Heine G.H. Monocyte heterogeneity in human cardiovascular disease. Immunobiology 2012, 217:1273-1284.
65. Zernecke A. MicroRNAs in the regulation of immune cell functions - implications for atherosclerotic vascular disease. Thromb. Haemost. 2012, 107:626-633.
66. Zhang H., Sunnarborg S.W., McNaughton K.K., Johns T.G., Lee D.C., Faber J.E. Heparin-binding epidermal growth factor-like growth factor signaling in flow-induced arterial remodeling. Circ. Res. 2008, 102:1275-1285.
67. Zhang Q., Kandic I., Kutryk M.J. Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochem. Biophys. Res. Commun. 2011, 405:42-46.
68. Zhao Y., Bruemmer D. NR4A orphan nuclear receptors in cardiovascular biology. Drug Discov. Today Dis. Mech. 2009, 6:e43-e48.
69. Ziegler-Heitbrock L., Hofer T.P. Toward a refined definition of monocyte subsets. Front. Immunol. 2013, 4:23.